Abbot - a major Covid test supplier in the US also seems to think a testing app has merit no matter what some may think.
We're pairing this $5, 15-minute, easy-to-use test with a mobile app, called NAVICA™, which works like a secure digital "boarding pass" that can be scanned to enter organizations and other places where people gather. This combination is life-changing technology that will attack the pandemic on critical fronts – speed, simplicity, affordability, access and reliability.
https://www.abbott.com/BinaxNOW-Test-NAVICA-App.html#/
https://youtu.be/dXWDYgSWv_k
Our lives have been shuffled and shuffled again ever since humanity was dealt the bad hand of COVID-19.
As vaccine research continues, health experts have pushed all-in to slow the spread of the disease through diagnostic testing, face coverings and social distancing.
Even still, each decision and every moment can feel a bit like a gamble with your health.
We don't like that. So, we're upping the testing ante again — and working to stack the cards in your favor.
Cue our sixth COVID-19 test, the BinaxNOW™ COVID-19 Ag Card rapid antigen test, which has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA). This test offers results in 15 minutes and is available as an aid to diagnose the virus that causes COVID-19.
The BinaxNOW test can be displayed on our new optional app — available at no charge — for iPhone and Android devices called NAVICA™. This first-of-its-kind app will allow people who test negative to have a temporary encrypted digital health pass that displays their results.
"We intentionally designed the BinaxNOW test and NAVICA app so we could offer a comprehensive testing solution to help Americans feel more confident about their health and lives," said Robert B. Ford, president and chief executive officer, Abbott. "BinaxNOW and the NAVICA app give us an affordable, easy-to-use and scalable test, and a digital health tool to help us have a bit more normalcy in our daily lives."
Here's How it Works
The healthcare worker opens the card and lays it flat on a countertop.
Extraction reagent is added to the test card, which is about the size of a credit card.
A nasal swab is taken from the patient.
A technician inserts the swab into the test card, folds over the cover and in 15 minutes, reads the result.
People who use the app and receive a negative test result will get a temporary encrypted digital health pass via a QR code (similar to an airline boarding pass) sent to the NAVICA app. The digital pass is renewed each time a person receives a negative test result and includes the date of the latest test result submission. Organizations will be able to view and verify the information on a mobile device to help make entry into these places easier, along with hand-washing, social distancing, enhanced cleaning and mask-wearing.
Those who test positive will receive a message through the app telling them to quarantine and talk to their doctor.
A Standout COVID-19 Test
The BinaxNOW test, which is for use by healthcare professionals, has features that make it desirable for testing millions. It's…
Easy to use.
Affordable.
Highly portable, requiring no instrumentation.
Reliable, with 97.1% sensitivity and 98.5% specificity.
Fast, with results in 15 minutes.
BinaxNOW COVID-19 Ag Card joins our previously launched tests, including high-volume m2000 and Alinity™ m molecular laboratory systems, ID NOW™ rapid molecular point-of-care platforms, antibody tests for our high-throughput ARCHITECT® i1000SR and i2000SR and Alinity i laboratory instruments. All are available in the U.S. through FDA EUAs.
We're pairing this $5, 15-minute, easy-to-use test with a mobile app, called NAVICA™, which works like a secure digital "boarding pass" that can be scanned to enter organizations and other places where people gather. This combination is life-changing technology that will attack the pandemic on critical fronts – speed, simplicity, affordability, access and reliability.
https://www.abbott.com/BinaxNOW-Test-NAVICA-App.html#/
https://youtu.be/dXWDYgSWv_k
Our lives have been shuffled and shuffled again ever since humanity was dealt the bad hand of COVID-19.
As vaccine research continues, health experts have pushed all-in to slow the spread of the disease through diagnostic testing, face coverings and social distancing.
Even still, each decision and every moment can feel a bit like a gamble with your health.
We don't like that. So, we're upping the testing ante again — and working to stack the cards in your favor.
Cue our sixth COVID-19 test, the BinaxNOW™ COVID-19 Ag Card rapid antigen test, which has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA). This test offers results in 15 minutes and is available as an aid to diagnose the virus that causes COVID-19.
The BinaxNOW test can be displayed on our new optional app — available at no charge — for iPhone and Android devices called NAVICA™. This first-of-its-kind app will allow people who test negative to have a temporary encrypted digital health pass that displays their results.
"We intentionally designed the BinaxNOW test and NAVICA app so we could offer a comprehensive testing solution to help Americans feel more confident about their health and lives," said Robert B. Ford, president and chief executive officer, Abbott. "BinaxNOW and the NAVICA app give us an affordable, easy-to-use and scalable test, and a digital health tool to help us have a bit more normalcy in our daily lives."
Here's How it Works
The healthcare worker opens the card and lays it flat on a countertop.
Extraction reagent is added to the test card, which is about the size of a credit card.
A nasal swab is taken from the patient.
A technician inserts the swab into the test card, folds over the cover and in 15 minutes, reads the result.
People who use the app and receive a negative test result will get a temporary encrypted digital health pass via a QR code (similar to an airline boarding pass) sent to the NAVICA app. The digital pass is renewed each time a person receives a negative test result and includes the date of the latest test result submission. Organizations will be able to view and verify the information on a mobile device to help make entry into these places easier, along with hand-washing, social distancing, enhanced cleaning and mask-wearing.
Those who test positive will receive a message through the app telling them to quarantine and talk to their doctor.
A Standout COVID-19 Test
The BinaxNOW test, which is for use by healthcare professionals, has features that make it desirable for testing millions. It's…
Easy to use.
Affordable.
Highly portable, requiring no instrumentation.
Reliable, with 97.1% sensitivity and 98.5% specificity.
Fast, with results in 15 minutes.
BinaxNOW COVID-19 Ag Card joins our previously launched tests, including high-volume m2000 and Alinity™ m molecular laboratory systems, ID NOW™ rapid molecular point-of-care platforms, antibody tests for our high-throughput ARCHITECT® i1000SR and i2000SR and Alinity i laboratory instruments. All are available in the U.S. through FDA EUAs.
